News & Articles
Latest updates, insights, and developments from Medlere.
Sharing progress in diagnostic innovation and industry knowledge that supports better healthcare decisions globally.
You are here: Home / News & Articles
The Role of POCT Devices in Early Screening of Cardiovascular Diseases.png
The Role of POCT Devices in Early Screening of Cardiovascular Diseases

Cardiovascular diseases remain the leading cause of death globally, making early detection critical for improving patient outcomes. This article explores how point-of-care testing (POCT) devices are transforming cardiovascular screening by enabling rapid, on-site detection of key biomarkers such as troponin, BNP, D-dimer, and hs-CRP. By significantly reducing turnaround time and supporting real-time clinical decision-making, POCT enhances efficiency in emergency, primary care, and remote settings. Backed by recommendations from leading organizations such as the World Health Organization and American Heart Association, POCT is emerging as a vital tool in preventive cardiology and decentralized healthcare systems.

READ MORE
04/ 21 / 2026
Medlere Showcases Advanced Diagnostic Solutions at CMEF 2026 in Shanghai.png
Medlere Showcases Advanced Diagnostic Solutions at CMEF 2026 in Shanghai

SHANGHAI, CHINA, April 2026 — Medlere, a global provider of in vitro diagnostic (IVD) solutions, participated in China International Medical Equipment Fair (CMEF 2026), held at the National Exhibition and Convention Center in Shanghai. Under the theme “Making Healthcare Simple,” Medlere presented its latest diagnostic technologies and engaged with distributors, laboratory professionals, and healthcare partners from around the world.

READ MORE
04/ 14 / 2026
Immunoassay vs Boronate Affinity vs HPLC.png
Choosing the Right HbA1c Testing Method: Immunoassay vs Boronate Affinity vs HPLC

Hemoglobin A1c (HbA1c) testing plays a critical role in the diagnosis and long-term management of diabetes. As clinical decisions increasingly rely on precise and standardized results, the choice of testing methodology becomes more important than ever. Among the most widely used technologies, Immunoassay, Boronate Affinity, and High-Performance Liquid Chromatography (HPLC) each offer distinct advantages and limitations. Understanding these differences is essential for laboratories aiming to balance efficiency, accuracy, and clinical reliability.

READ MORE
04/ 09 / 2026
Medlere M3 HPLC HbA1c Analyzer with Cap Piercing and Thalassemia Screening.png
Beyond HbA1c Testing: Overcoming Hemoglobin Variant Interference and Improving Lab Efficiency

Master HbA1c precision with Medlere M3 HPLC Analyzer. Solve variant interference and enable thalassemia screening with Ion-exchange HPLC technology.

READ MORE
03/ 27 / 2026
2026年1月27日.png
Why Test Hormones – A Diagnostic Perspective on Hormone Testing and Its Clinical Value

Hormones as the Body’s Hidden SignalsHormones are chemical messengers that regulate nearly every major physiological process in the human body — reproduction, metabolism, growth, mood, and aging. Unlike many routine biomarkers, hormone levels are dynamic, inter‑connected, and highly sensitive to phy

READ MORE
01/ 27 / 2026
HbA1c.png
Understanding the A1C Test: A Three-Month Picture of Your Blood Sugar

The A1C test—also known as HbA1c, glycated hemoglobin, or glycosylated hemoglobin—is a simple blood test that reflects your average blood glucose level over the past three months. It is one of the most important tools for screening, diagnosing, and monitoring diabetes and prediabetes. Our range of analyzers offers multiple technologies for HbA1c testing: 1️⃣ FiCA Immunofluorescence Analyzer – enabling rapid HbA1c testing in point-of-care settings. 2️⃣ UClia POCT CLIA Analyzer – combining high sensitivity and convenience for on-site HbA1c analysis. 3️⃣ M3 HPLC HbA1c Analyzer – providing gold-standard precision for laboratory-level HbA1c measurement. 显示译文

READ MORE
10/ 28 / 2025
67cabd8f-8740-40b2-a456-8086f9bd07a1.png
Clinical Applications of Anti-Müllerian Hormone (AMH)

AMH serves as a powerful, stable marker of female reproductive health — from assessing fertility potential and guiding assisted reproduction, to detecting ovarian disorders. Regular monitoring of AMH not only empowers women with insight into their fertility timeline but also enables early, informed decisions about reproductive planning. At Medlere, we are dedicated to supporting reproductive and endocrine health through advanced diagnostic innovation. Both our FiCA Immunofluorescence Analyzer and UClia POCT CLIA Analyzer provide reliable and accurate AMH testing solutions, offering clinicians versatile options for routine and point-of-care testing environments.

READ MORE
10/ 15 / 2025
Platelet.png
Platelet Aggregation: Why Is It So Important for Our Health?

Testing platelet aggregation is like giving the body's "bleeding control system" a check-up. Too weak → bleeding that won't stop.mToo strong → higher risk of blood clots. Such testing not only helps doctors find the reasons behind bleeding or clotting issues, but also guides medication and surgical decisions, making treatments safer and more precise.

READ MORE
09/ 19 / 2025
PSA.png
Understanding tPSA and fPSA: Key Markers in Prostate Health Assessment

Prostate cancer is one of the most common malignancies in men, and its early detection greatly improves treatment outcomes. Among the various biomarkers used in screening and diagnosis, total prostate-specific antigen (tPSA) and free prostate-specific antigen (fPSA) play a pivotal role in evaluating prostate health and differentiating benign from malignant conditions.

READ MORE
08/ 13 / 2025
pipette.png
How To Choose The Appropriate Pipette Volume Range

Selecting the correct pipette volume is essential for achieving accurate and precise liquid handling and testing results. Optimal Working RangeYour target volume should ideally fall within 35% to 100% of the pipette’s total volume capacity.

READ MORE
07/ 23 / 2025

Who We Are

With the ultimate goal of making a positive impact on the health and wellbeing of people everywhere.
Contact Us
Address: 291 Brighton Road South Croydon United Kingdom Cr2 6Eq    E-mail: info@medlere.com    Tel.: +447565748991
The content on the Medlere website may showcase some of our forthcoming care offerings, which are currently under development. Please note that these offerings are subject to completion of the development process and may require regulatory authorization, clearance, or approval before they can be made available for commercial use.
@​2023 Medlere Limited. All Rights Reserved.